The 2023 Report on Pharma Contract Sales: World Market Segmentation by City

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market. In this report we define the sales of pharma contract sales as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Actavis, Actelion Pharmaceuticals, Addison Whitney, Adheris Health, Akrikhin, Alexion, Allergan, Amgen, Andrx Pharmaceutials, Inc., Apple, Aralez Pharmaceuticals, Arbor Pharms Ireland, Arena Pharmaceuticals, Argon Global Healthcare Network, ARIAD, Arista, Ashfield Healthcare, AstraZeneca, BASF Schweiz, Bayer Healthcare, Berkshire Sterile Manufacturing (BSM), Biogaran, Blue Earth Diagnostics Limited., Boehringer Ingelheim, Bristol-Myers Squibb, Brusilow Enterprises, LLC, Campbell Alliance, Cegedim, Celesio, Celgene, Clovis Oncology, CMIC Ashfield, Create NYC, Daiichi Sankyo, Dendreon, Depomed, Eisai, Eli Lilly, Encore Health Resources, Endo Pharmaceuticals, Expansis, Galliard, Genentech, GlaxoSmithKline, Grey Healthcare Group, Group DCA, GSW, Haymarket Media, Health Kare Pharma International, In2Focus, INC Research, Ingelheim, inVentiv Health, Invida, IQVIA, J&J, J. Knipper & Company, Inc., Janssen Biotech, Kadrige, Knowledge Point360, Kos Pharmaceuticals, Marvecs, Medical Communications Group (MCG), MediMedia Health, Menarini, Merck, Merrimack, Microsoft, Millennium Pharmaceuticals, Mylan N.V., Navicor, Neurocrine Biosciences, NovaMed Pharmaceuticals, Novartis, Novella Clinical, Novo Nordisk, OnCall, Oracle, Otsuka/Bristol-Myers Squibb, PALIO, Parexel International, PDI, Pegasus, Pfizer, Pharmagistics, Pharmexx, Polpharma, Promius Pharma, Publicis Healthcare Communications Group (PHCG), Qforma, Quantia, Quintiles, Ramco Import Export, Regulus Therapeutics, Roche, Salesforce.com, Sanofi, Schering-Plough, Scientific Voice, Sermo, Servier, Sinclair IS Pharma, SmartAnalyst, Smithkline Beecham, Sofip (Société de Franchise pour l'Information Pharmaceutique), StayinFront, Symplmed Pharmaceuticals, Syneos Health, Synopia Rx, Taiho Oncology, Takeda, Tardis Medical, Temas, Tesaro, Teva Pharmaceutical Industries, The Medicines Company, United Therapeutics, Veeva, Vivus, and Zuellig Group. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).